Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Genetics of Diabetic Kidney Disease-From the Worst of Nightmares to the Light of Dawn?

Ma RC, Cooper ME.

J Am Soc Nephrol. 2017 Feb;28(2):389-393. doi: 10.1681/ASN.2016091028. Epub 2016 Nov 23. No abstract available.

2.

Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27).

Raman R, Gupta A, Krishna S, Kulothungan V, Sharma T.

J Diabetes Complications. 2012 Mar-Apr;26(2):123-8. doi: 10.1016/j.jdiacomp.2012.02.001. Epub 2012 Mar 24.

PMID:
22446033
3.

Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.

Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ.

Am J Kidney Dis. 2012 Jan;59(1):75-83. doi: 10.1053/j.ajkd.2011.09.017. Epub 2011 Nov 3.

PMID:
22051245
4.

Advances in early biomarkers of diabetic nephropathy.

Zhang J, Liu J, Qin X.

Rev Assoc Med Bras (1992). 2018 Jan;64(1):85-92. doi: 10.1590/1806-9282.64.01.85. Review.

5.

The study of association of Vitamin B12 deficiency in type 2 diabetes mellitus with and without diabetic nephropathy in North Indian Population.

Bherwani S, Ahirwar AK, Saumya AS, Sandhya AS, Prajapat B, Patel S, Jibhkate SB, Singh R, Ghotekar LH.

Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S365-S368. doi: 10.1016/j.dsx.2017.03.017. Epub 2017 Mar 6.

PMID:
28283394
6.

[Diabetic nephropathy and molecular biology of the renin-angiotensin system in the diabetic kidney].

Rodríguez Pérez JC, Barrio Castellanos R.

Med Clin (Barc). 1995 Nov 25;105(18):708-15. Review. Spanish. No abstract available.

PMID:
8538254
7.

Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).

Schutte E, Lambers Heerspink HJ, Lutgers HL, Bakker SJ, Vart P, Wolffenbuttel BH, Umanath K, Lewis JB, de Zeeuw D, Gansevoort RT.

Am J Kidney Dis. 2015 Sep;66(3):450-8. doi: 10.1053/j.ajkd.2015.03.032. Epub 2015 May 16.

PMID:
25987260
8.

Expression of (pro)renin receptor in human kidneys with end-stage kidney disease due to diabetic nephropathy.

Takahashi K, Yamamoto H, Hirose T, Hiraishi K, Shoji I, Shibasaki A, Kato I, Kaneko K, Sasano H, Satoh F, Totsune K.

Peptides. 2010 Jul;31(7):1405-8. doi: 10.1016/j.peptides.2010.04.003. Epub 2010 Apr 10.

PMID:
20385187
9.

Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation.

Lee SH, Lee TW, Ihm CG, Kim MJ, Woo JT, Chung JH.

Nephrology (Carlton). 2005 Oct;10 Suppl:S32-6. Review.

PMID:
16174285
10.

The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.

Conserva F, Pontrelli P, Accetturo M, Gesualdo L.

J Nephrol. 2013 Sep-Oct;26(5):811-20. doi: 10.5301/jn.5000262. Epub 2013 Mar 27. Review.

PMID:
23543479
11.

[Diabetic nephropathy].

Weekers L, Krzesinski JM.

Rev Med Liege. 2005 May-Jun;60(5-6):479-86. Review. French.

12.

Diabetic nephropathy--the family physician's role.

Roett MA, Liegl S, Jabbarpour Y.

Am Fam Physician. 2012 May 1;85(9):883-9.

13.

Diabetic nephropathy: of mice and men.

Breyer MD, Böttinger E, Brosius FC, Coffman TM, Fogo A, Harris RC, Heilig CW, Sharma K.

Adv Chronic Kidney Dis. 2005 Apr;12(2):128-45. Review.

PMID:
15822049
14.

Uromodulin gene variant is associated with type 2 diabetic nephropathy.

Ahluwalia TS, Lindholm E, Groop L, Melander O.

J Hypertens. 2011 Sep;29(9):1731-4. doi: 10.1097/HJH.0b013e328349de25.

PMID:
21738052
15.

Early recurrence of diabetic nodular sclerosis in a kidney transplant recipient.

Pavan M, Ranganath R, Chaudhari AP.

Iran J Kidney Dis. 2012 May;6(3):219-21.

16.

The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters.

Al-Rubeaan K, Siddiqui K, Alghonaim M, Youssef AM, AlNaqeb D.

Ann Saudi Med. 2018 Jan-Feb;38(1):46-56. doi: 10.5144/0256-4947.2018.03.01.1010. Epub 2018 Jan 3.

17.

Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.

Mohamed R, Jayakumar C, Chen F, Fulton D, Stepp D, Gansevoort RT, Ramesh G.

J Am Soc Nephrol. 2016 Mar;27(3):745-65. doi: 10.1681/ASN.2014111136. Epub 2015 Sep 2.

18.

Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.

Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, Klein JB, Ng DP, Placha G, Canani LH, Bochenski J, Waggott D, Merchant ML, Krolewski B, Mirea L, Wanic K, Katavetin P, Kure M, Wolkow P, Dunn JS, Smiles A, Walker WH, Boright AP, Bull SB; DCCT/EDIC Research Group, Doria A, Rogus JJ, Rich SS, Warram JH, Krolewski AS.

Diabetes. 2009 Jun;58(6):1403-10. doi: 10.2337/db08-1514. Epub 2009 Feb 27.

19.

[Current issues in the diagnosis and therapy of diabetic nephropathy].

de Châtel R, Mogyorósi A, Ziyadeh FN.

Orv Hetil. 1997 Jan 26;138(4):187-93. Review. Hungarian.

PMID:
9072751
20.

Kidney disease of diabetes mellitus (diabetic nephropathy): perspectives in the United States.

Striker GE, Agodoa LL, Held P, Doi T, Conti F, Striker LJ.

J Diabet Complications. 1991 Apr-Sep;5(2-3):51-2. Review. No abstract available.

PMID:
1770051

Supplemental Content

Support Center